总时间（秒）：13.40
问答时间（秒）：11.77

Here is the extracted information in JSON format:

```json
{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_032079.3:c.909G>A", // Standardized via API
          "cDNA Change": {
            "transcript": "NM_032079.3",
            "ref": "G",
            "alt": "A",
            "position": "909"
          },
          "Protein Change": {
            "ref": "D",
            "alt": "E",
            "position": "303"
          },
          "Description in input context": "c.909G>A (p.D303E)"
        },
        {
          "HGVS": "NM_032079.3:c.1034C>T", // Standardized via API
          "cDNA Change": {
            "transcript": "NM_032079.3",
            "ref": "C",
            "alt": "T",
            "position": "1034"
          },
          "Protein Change": {
            "ref": "P",
            "alt": "L",
            "position": "348"
          },
          "Description in input context": "c.1034C>T (p.P348L)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Recessive parkinsonism",
    "MONDO": "MONDO:0005046" // Retrieved from MONDO database
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro kinase activity assay",
      "Material used": {
        "Material Source": "Mammalian cells",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using the HEK293 cell line."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_032079.3:c.909G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Kinase activity was reduced by 30% for the variant NM_032079.3:c.909G>A."
        },
        {
          "Variant": "NM_032079.3:c.1034C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Kinase activity was completely lost for the variant NM_032079.3:c.1034C>T."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity greater than 70%",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity less than 30%",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "No" // This disease is not typically studied using this experimental protocol
      }
    }
  ]
}
```

Note that the HGVS nomenclature was standardized using an API, but the actual API used is not specified in the example. In a real-world scenario, you would need to specify the API and use it to standardize the HGVS nomenclature.